Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deep sequencing reveals increased DNA methylation in chronic rat epilepsy
Katja Kobow, Antony Kaspi, K N Harikrishnan, et al.
Acta Neuropathologica (2013) Vol. 126, Iss. 5, pp. 741-756
Open Access | Times Cited: 191

Showing 26-50 of 191 citing articles:

Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?
Marwa Elamin, David N. Ruskin, Susan A. Masino, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 88
Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration
Ruijun Li, Yang Liu, Huan‐Qiu Liu, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 3
Open Access | Times Cited: 79
ATP and adenosine—Two players in the control of seizures and epilepsy development
Edward Beamer, Manvitha Kuchukulla, Detlev Boison, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102105-102105
Open Access | Times Cited: 74
The DNA Methylation in Neurological Diseases
Samareh Younesian, Amir‐Mohammad Yousefi, Majid Momeny, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3439-3439
Open Access | Times Cited: 66
Astrocyte-neuron circuits in epilepsy
Benton S. Purnell, Mariana Alves, Detlev Boison
Neurobiology of Disease (2023) Vol. 179, pp. 106058-106058
Open Access | Times Cited: 39
Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy
Saima Khatoon, Nida Kalam
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Profiling status epilepticus-induced changes in hippocampal RNA expression using high-throughput RNA sequencing
Katelin F. Hansen, Kensuke Sakamoto, Carl Pelz, et al.
Scientific Reports (2014) Vol. 4, Iss. 1
Open Access | Times Cited: 95
The ketogenic diet for the treatment of malignant glioma
Eric C. Woolf, Adrienne C. Scheck
Journal of Lipid Research (2014) Vol. 56, Iss. 1, pp. 5-10
Open Access | Times Cited: 89
Comorbidities in Neurology: Is adenosine the common link?
Detlev Boison, Eleonora Aronica
Neuropharmacology (2015) Vol. 97, pp. 18-34
Open Access | Times Cited: 89
Epigenetics in epilepsy
Katja Kobow, Ingmar Blümcke
Neuroscience Letters (2017) Vol. 667, pp. 40-46
Closed Access | Times Cited: 83
Ketone Bodies as Anti-Seizure Agents
Timothy A. Simeone, Kristina A. Simeone, Jong M. Rho
Neurochemical Research (2017) Vol. 42, Iss. 7, pp. 2011-2018
Open Access | Times Cited: 80
Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia
Katja Kobow, Mark Ziemann, Harikrishnan Kaipananickal, et al.
Epilepsia (2019) Vol. 60, Iss. 6, pp. 1091-1103
Open Access | Times Cited: 72
Ketone bodies as epigenetic modifiers
Hai‐Bin Ruan, Peter A. Crawford
Current Opinion in Clinical Nutrition & Metabolic Care (2018) Vol. 21, Iss. 4, pp. 260-266
Closed Access | Times Cited: 62
The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine
Detlev Boison
Frontiers in Molecular Neuroscience (2016) Vol. 9
Open Access | Times Cited: 61
Role of Adenosine in Epilepsy and Seizures
Fabio Tescarollo, Diogo M. Rombo, Lindsay K. DeLiberto, et al.
Journal of Caffeine and Adenosine Research (2020) Vol. 10, Iss. 2, pp. 45-60
Open Access | Times Cited: 57
Effects of ketogenic diet and ketone bodies on the cardiovascular system: Concentration matters
Souad Nasser, Varvara Vialichka, Marta Biesiekierska, et al.
World Journal of Diabetes (2020) Vol. 11, Iss. 12, pp. 584-595
Open Access | Times Cited: 57
Epigenetic mechanisms of neurodegenerative diseases and acute brain injury
Mario J. Bertogliat, Kahlilia C. Morris-Blanco, Raghu Vemuganti
Neurochemistry International (2019) Vol. 133, pp. 104642-104642
Open Access | Times Cited: 55
β-Hydroxybutyrate as an epigenetic modifier: Underlying mechanisms and implications
Yanqiu He, Xi Cheng, Tingting Zhou, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21098-e21098
Open Access | Times Cited: 20
Metabolism and epilepsy: Ketogenic diets as a homeostatic link
Susan A. Masino, Jong M. Rho
Brain Research (2018) Vol. 1703, pp. 26-30
Open Access | Times Cited: 59
Control of seizures by ketogenic diet-induced modulation of metabolic pathways
Ryan Clanton, Guoyao Wu, Gamal Akabani, et al.
Amino Acids (2016) Vol. 49, Iss. 1, pp. 1-20
Closed Access | Times Cited: 54
Epigenetic mechanisms in epilepsy
Katja Kobow, Ingmar Blümcke
Progress in brain research (2014), pp. 279-316
Closed Access | Times Cited: 52
Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice
Ursula S. Sandau, Mayadah Yahya, Ryan Bigej, et al.
Epilepsia (2019) Vol. 60, Iss. 4, pp. 615-625
Open Access | Times Cited: 52
Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies
Detlev Boison, Jong M. Rho
Neuropharmacology (2019) Vol. 167, pp. 107741-107741
Open Access | Times Cited: 51
Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies
Krzysztof Łukawski, Marta Andres‐Mach, Mirosław Czuczwar, et al.
Pharmacological Reports (2017) Vol. 70, Iss. 2, pp. 284-293
Closed Access | Times Cited: 49
Ketogenic diet, neuroprotection, and antiepileptogenesis
Madhuvika Murugan, Detlev Boison
Epilepsy Research (2020) Vol. 167, pp. 106444-106444
Open Access | Times Cited: 43

Scroll to top